Data Sheet 1_The effects of resveratrol on endothelial progenitor cells and apoptosis biom

A dataset from a randomized controlled trial investigating the effects of resveratrol on endothelial progenitor cells and apoptosis biomarkers in postmenopausal women with chronic coronary heart disease. The study involved 20 participants allocated to receive either 1,000 mg of resveratrol or a placebo for 90 days. It was authored by Gustavo Henrique Ferreira Gonçalinho and last updated in May 2026.

Use Cases

• Analyze the effect of resveratrol on apoptosis biomarkers like caspases and Bcl-2 based on the described serum measurements.
• Model the relationship between phytoestrogen treatment and endothelial progenitor cell (EPC) counts based on CD34+/KDR+ cell data.
• Investigate correlations between sirtuin levels (SIRT1, SIRT3) and other cardiovascular biomarkers mentioned in the results.
• Compare intervention and placebo group outcomes for cytokines, lipid profile, glucose, and blood pressure as described.

Strengths

• Data originates from a structured randomized controlled trial with a placebo group.
• Includes measurements for multiple specific biomarkers (e.g., caspases 3 and 9, survivin, cIAP2, XIAP, Bcl-2, cytochrome c).
• License is CC-BY-4.0, permitting broad reuse with attribution.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• The dataset is small (64.0 KB), indicating a limited scope likely corresponding to the 20 participants.

Provenance

Source

figshare

Collection Method

Data collected from a 90-day randomized controlled trial with 20 postmenopausal women with chronic coronary heart disease.

Freshness

Last updated 2026-05-14 04:30:13; freshness should be verified.